You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

conjunctival inflammation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pterygium, Ocular Pain, Ocular Inflammation Trial in Guadalajara, Ciudad de México (PRO-155, Placebo)

Completed
Has Results
  • Pterygium
  • +3 more
  • Guadalajara, Jalisco, Mexico
  • +2 more
Oct 30, 2019

Ocular Surface Disease in Chronic Graft-Versus-Host Disease

Recruiting
  • Dry Eye
  • GVHD
  • Cross-sectional study
  • Singapore, Singapore
    Cynthia Boo
Mar 22, 2022

Dry Eye Trial in Guangzhou (Cyclosporine, oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp

Recruiting
  • Dry Eye
  • Cyclosporine
  • oculus keratograph, in vivo laser confocal microscopy, Functional slit lamp biomicroscopy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Feb 9, 2022

Pterygium Trial in New York (Dexamethasone Intracanalicular Insert, 0.4mg, Prednisolone Acetate 1%)

Completed
  • Pterygium
  • Dexamethasone Intracanalicular Insert, 0.4mg
  • Prednisolone Acetate 1%
  • New York, New York
    New York Eye Specialists
Apr 4, 2022

Inflammation, Cataract Surgery Trial in Valinhos (Ster, Pred Fort)

Completed
  • Inflammation
  • Cataract Surgery
  • Valinhos, São Paulo, Brazil
    LAL Clínica Pesquisa e Desenvolvimento Ltda
Oct 31, 2022

Ocular Inflammation, Ocular Prostheses Trial in Rennes (Hydrocortisone, Dexamethasone, Povidone)

Not yet recruiting
  • Ocular Inflammation
  • Ocular Prostheses
  • Rennes, France
    Centre Hospitalier Universitaire de Rennes _ Pontchaillou
Dec 20, 2022

Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome

Recruiting
  • Autoimmunity
  • Dry Eye Syndrome
  • Cross-sectional study
  • Singapore, Singapore
    Cynthia Boo
Mar 22, 2022

Trachoma Trial in Niamey (Azithromycin)

Recruiting
  • Trachoma
  • Niamey, Niger
    Programme National de Santé Oculaire (PNSO)
Aug 3, 2022

High-risk Corneal Transplantation, Corneal Blindess, Corneal Inflammation Trial (CLP-PEG-MPC, Human donor cornea penetrating

Withdrawn
  • High-risk Corneal Transplantation
  • +3 more
  • CLP-PEG-MPC
  • Human donor cornea penetrating keratoplasty
  • (no location specified)
Dec 19, 2022

Herpes Simplex Dendritic Keratitis Trial in Portland (Prokera Slim, Standard of Care)

Withdrawn
  • Herpes Simplex Dendritic Keratitis
  • Prokera Slim
  • Standard of Care
  • Portland, Oregon
    Casey Eye Institute, Oregon Health & Science University
Sep 19, 2022

Dry Eye Disease Trial in Shenyang (Orthokeratology, Spectacles)

Not yet recruiting
  • Dry Eye Disease
  • Orthokeratology
  • Spectacles
  • Shenyang, Liaoning, China
    He Eye Hospital
Aug 29, 2023

Dry Eye, Dry Eye Syndromes, Cataract Trial in Brampton (dietary supplement, drug, other)

Not yet recruiting
  • Dry Eye
  • +2 more
  • Omega-3
  • +3 more
  • Brampton, Ontario, Canada
    Uptown Eye
Aug 6, 2023

Ocular Surface in Primary Open Angle Glaucoma or Ocular

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
    • Valladolid, Spain
      IOBA
    Jan 28, 2022

    Dry Eye Trial in Shenyang (Intense pulsed light, Diquafosol tetrasodium)

    Not yet recruiting
    • Dry Eye
    • Intense pulsed light
    • Diquafosol tetrasodium
    • Shenyang, Liaoning, China
      He Eye Hospital
    Jan 19, 2023

    Pterygium Trial in Assiut (intraoperative subconjunctival injection of triamcinolone acetonide and limited peritomy during bare

    Completed
    • Pterygium
    • intraoperative subconjunctival injection of triamcinolone acetonide and limited peritomy during bare scleral pterygium excision
    • Assiut, Egypt
      Alaa M. Abdelhafez
    Feb 20, 2021

    Trachoma Trial in San Francisco, Bahir Dar (Azithromycin)

    Recruiting
    • Trachoma
    • San Francisco, California
    • +1 more
    Feb 22, 2022

    Diabetic Eye Problems Trial in Shenyang (3% Diquafosol tetrasodium, 0.1% hyaluronate)

    Not yet recruiting
    • Diabetic Eye Problems
    • 3% Diquafosol tetrasodium
    • 0.1% hyaluronate
    • Shenyang, Liaoning, China
      He Eye Hospital
    Jan 10, 2023

    Pterygium of Conjunctiva and Cornea Trial in Split (Cauterization, Fibrin glue)

    Recruiting
    • Pterygium of Conjunctiva and Cornea
    • Cauterization
    • Fibrin glue
    • Split, Croatia
      University Hospital Split
    Nov 1, 2022

    Pterygium Trial in Ariana (Preoperative Intra-lesional Bevacizumab Injection in primary pterygium, pterygium surgery without

    Completed
    • Pterygium
    • Preoperative Intra-lesional Bevacizumab Injection in primary pterygium
    • pterygium surgery without adjunctive therapy
    • Ariana, Illinois, Tunisia
      Dhouha Gouider
    Apr 3, 2022

    Dry Eye Disease Trial in Boston (Lotemax, Soothe Tired Eyes Lubricant Eye Drop (Artificial Tears), In Vivo Confocal Microscopy

    Completed
    Has Results
    • Dry Eye Disease
    • Boston, Massachusetts
      Tufts Medical Center
    Feb 24, 2022

    Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)

    Not yet recruiting
    • Dry Eye Disease
    • Topical spironolactone ophthalmic solution, 0.005 mg/cc
    • Placebo
    • Bellaire, Texas
      Richard W Yee, MD PLLC
    Aug 16, 2023

    Micro- and Macrovascular Parameters in Delayed Cerebral Ischemia

    Not yet recruiting
    • Delayed Cerebral Ischemia
    • Aneurysmal Subarachnoid Hemorrhage
      • (no location specified)
      Aug 2, 2022

      Allergic Conjunctivitis Trial (Lastacaft ®, Tears Naturale ® (Placebo))

      Completed
      Has Results
      • Allergic Conjunctivitis
      • Lastacaft ®
      • Tears Naturale ® (Placebo)
      • (no location specified)
      Feb 24, 2021

      Dry Eye Trial in Birmingham (Amniotic membrane Omnigen[TM], Bandage soft Contact Lens OmniLenz[R])

      Recruiting
      • Dry Eye
      • Amniotic membrane Omnigen[TM]
      • Bandage soft Contact Lens OmniLenz[R]
      • Birmingham, West Midlands, United Kingdom
        Aston University
      Jul 25, 2022

      Dry Eye Trial in Baltimore (Sustained Release Dexamethasone, 0.4 mg, E-Caprolactone-L-Lactide copolymer (PCL) punctal plug)

      Recruiting
      • Dry Eye
      • Sustained Release Dexamethasone, 0.4 mg
      • E-Caprolactone-L-Lactide copolymer (PCL) punctal plug
      • Baltimore, Maryland
        Wilmer Eye Institute, Johns Hopkins School of Medicine
      Jan 24, 2022